Translational Drug Development (TD2)
Stephanie N. currently works as a Data Specialist II at Translational Drug Development (TD2), a position held since December 2019, following roles as a Senior Research Associate and Preclinical Research Associate. Previous experience includes serving as a Graduate Research and Teaching Assistant and a Graduate Research Assistant in the Psychology Department at the University of Arizona from 2014 to 2019, along with research assistant positions at the University of Nevada-Las Vegas and the University of Arizona. Stephanie N. has a Master of Arts in Experimental Psychology with a Neuroscience minor from the University of Arizona and a Bachelor's degree in Psychology from the University of Nevada-Las Vegas. Additional training includes completion of programs in medical transcription, phlebotomy, and nursing assistance.
This person is not in the org chart
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.